Price T Rowe Associates Inc Trans Medics Group, Inc. Transaction History

Price T Rowe Associates Inc

$935 Billion
Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 398,160 shares of TMDX stock, worth $45.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

398,160

Previous 137,890 188.75%

Holding current value

$45.8 Million

Previous $18.5 Million 141.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$103.61 - $132.04 $27 Million - $34.4 Million	260,270 Added 188.75%	398,160 $44.7 Million
Q2 2025 Aug 14, 2025	BUY	$67.67 - $143.04 $148,332 - $313,543	2,192 Added 1.62%	137,890 $18.5 Million
Q1 2025 May 14, 2025	SELL	$56.73 - $79.42 $6.97 Million - $9.76 Million	-122,947 Reduced 47.54%	135,698 $9.13 Million
Q4 2024 Feb 14, 2025	SELL	$59.28 - $144.9 $2.06 Million - $5.05 Million	-34,821 Reduced 11.87%	258,645 $16.1 Million
Q3 2024 Nov 14, 2024	SELL	$135.68 - $176.11 $5.02 Million - $6.51 Million	-36,968 Reduced 11.19%	293,466 $46.1 Million
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $2.4 Million - $4.99 Million	33,110 Added 11.14%	330,434 $49.8 Million
Q1 2024 May 15, 2024	BUY	$70.86 - $89.93 $1.57 Million - $2 Million	22,223 Added 8.08%	297,324 $22 Million
Q4 2023 Feb 14, 2024	BUY	$36.74 - $81.08 $5.65 Million - $12.5 Million	153,861 Added 126.91%	275,101 $21.7 Million
Q3 2023 Nov 14, 2023	BUY	$53.47 - $96.07 $5.63 Million - $10.1 Million	105,319 Added 661.51%	121,240 $6.64 Million
Q2 2023 Aug 14, 2023	BUY	$66.23 - $88.73 $58,282 - $78,082	880 Added 5.85%	15,921 $1.34 Million
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $28,370 - $43,552	529 Added 3.65%	15,041 $1.14 Million
Q4 2022 Feb 14, 2023	BUY	$39.08 - $64.29 $11,255 - $18,515	288 Added 2.02%	14,512 $896,000
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $183,142 - $323,517	5,803 Added 68.91%	14,224 $594,000
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $3,515 - $5,497	171 Added 2.07%	8,421 $265,000
Q1 2022 May 16, 2022	SELL	$12.58 - $26.94 $2.24 Million - $4.8 Million	-178,013 Reduced 95.57%	8,250 $222,000
Q4 2021 Feb 14, 2022	BUY	$19.16 - $32.68 $3.57 Million - $6.09 Million	186,263 New	186,263 $3.57 Million
Q1 2021 May 17, 2021	SELL	$17.75 - $47.82 $5.98 Million - $16.1 Million	-336,789 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$11.91 - $19.9 $4.01 Million - $6.7 Million	336,789 New	336,789 $6.7 Million

Others Institutions Holding TMDX

# of Institutions

437

Shares Held

30.4M

Call Options Held

1.03M

Put Options Held

934K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.66B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Trans Medics Group, Inc. Transaction History